More on Anti-Insulin Receptor Antibody in Malignant Insulinoma and Refractory Hypoglycemia. Reply
N Engl J Med
.
2023 Oct 26;389(17):1635.
doi: 10.1056/NEJMc2311041.
Authors
Soravis Osataphan
1
,
Ahmed Rattani
1
,
Mary-Elizabeth Patti
2
Affiliations
1
Beth Israel Deaconess Medical Center, Boston, MA.
2
Joslin Diabetes Center, Boston, MA maryelizabeth.patti@joslin.harvard.edu.
PMID:
37888936
DOI:
10.1056/NEJMc2311041
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Hypoglycemia* / etiology
Insulinoma* / complications
Pancreatic Neoplasms* / complications